{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:39:19Z","timestamp":1781311159961,"version":"3.54.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:00:00Z","timestamp":1703980800000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.clinbiochem.2022.12.014","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T11:12:23Z","timestamp":1672225943000},"page":"17-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipients"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7991-1733","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Truffot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Jourdil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Veyret-Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-0392","authenticated-orcid":false,"given":"Johan","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Stanke-Labesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clinbiochem.2022.12.014_b0005","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/TP.0000000000001344","article-title":"Costimulation blockade in kidney transplantation: An update","volume":"100","author":"Malvezzi","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.12.014_b0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/FTD.0000000000000179","article-title":"Therapeutic drug monitoring of belatacept in kidney transplantation","volume":"37","author":"de Graav","year":"2015","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.12.014_b0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/1744666X.2019.1574570","article-title":"Belatacept in kidney transplantation and its limitations","volume":"15","author":"Noble","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.12.014_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FTD.0000000000000580","article-title":"A fully automated method for the determination of serum belatacept and its application in a pharmacokinetic investigation in renal transplant recipients","volume":"41","author":"Klaasen","year":"2019","journal-title":"Ther. Drug Monit. f\u00e9vr"},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.12.014_b0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40261-013-0153-2","article-title":"Pharmacokinetics, pharmacodynamics, and immunogenicity of belatacept in adult kidney transplant recipients","volume":"34","author":"Shen","year":"2014","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.clinbiochem.2022.12.014_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jim.2019.06.014","article-title":"Multiplexed monitoring of therapeutic antibodies for inflammatory diseases using Fab-selective proteolysis nSMOL coupled with LC-MS","volume":"472","author":"Iwamoto","year":"2019","journal-title":"J. Immunol .Methods."},{"key":"10.1016\/j.clinbiochem.2022.12.014_b0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.aca.2019.03.033","article-title":"A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn\u2019s disease","volume":"1067","author":"Willeman","year":"2019","journal-title":"Anal. Chim Acta"},{"key":"10.1016\/j.clinbiochem.2022.12.014_b0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clinbiochem.2020.10.007","article-title":"Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits","volume":"87","author":"Truffot","year":"2021","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.12.014_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jcm11010091","article-title":"Tocilizumab trough levels variability in kidney-transplant candidates undergoing desensitization","volume":"11","author":"Truffot","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.clinbiochem.2022.12.014_b0050","unstructured":"SH-GTA-04.pdf."},{"key":"10.1016\/j.clinbiochem.2022.12.014_b0055","unstructured":"Food and Drug Administration. Bioanalytical Method Validation - Guidance for Industry. 2018."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202200296X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202200296X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:58:31Z","timestamp":1757865511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991202200296X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":11,"alternative-id":["S000991202200296X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.12.014","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}